Literature DB >> 6024508

The use of immunologically competent cells in the treatment of cancer. Further experiments with a transplantable mouse tumour.

M O Symes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6024508      PMCID: PMC2008073          DOI: 10.1038/bjc.1967.18

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  6 in total

1.  IMMUNOLOGICAL ASPECTS OF CANCER.

Authors:  M F WOODRUFF
Journal:  Lancet       Date:  1964-08-08       Impact factor: 79.321

2.  PRELIMINARY OBSERVATIONS ON TREATMENT OF ADVANCED CANCER BY INJECTION OF ALLOGENEIC SPLEEN CELLS.

Authors:  M F WOODRUFF; B NOLAN
Journal:  Lancet       Date:  1963-08-31       Impact factor: 79.321

3.  THE EFFECT OF INTRAPERITONEAL INJECTION OF THORACIC DUCT LYMPHOCYTES FROM NORMAL AND IMMUNIZED RATS IN MICE INOCULATED WITH THE LANDSCHUTZ ASCITES TUMOUR.

Authors:  M F WOODRUFF; M O SYMES; N F ANDERSON
Journal:  Br J Cancer       Date:  1963-09       Impact factor: 7.640

4.  The use of immunologically competent cells in the treatment of cancer: experiments with a transplantable mouse tumour.

Authors:  M F WOODRUFF; M O SYMES
Journal:  Br J Cancer       Date:  1962-12       Impact factor: 7.640

5.  INHIBITORY EFFECT OF PRE-IMMUNIZED CBA SPLEEN CELLS ON TRANSPLANTS OF A-STRAIN MOUSE MAMMARY CARCINOMA IN (CBA X A) F1 HYBRID RECIPIENTS.

Authors:  M F WOODRUFF; J L BOAK
Journal:  Br J Cancer       Date:  1965-06       Impact factor: 7.640

6.  THE EFFECT OF RAT SPLEEN CELLS ON TWO TRANSPLANTED MOUSE TUMOURS.

Authors:  M F WOODRUFF; M O SYMES; A E STUART
Journal:  Br J Cancer       Date:  1963-06       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.